# Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma

> **NCT01621880** · PHASE2 · COMPLETED · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 112 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma
- Adverse Effect of Radiation Therapy
- Brain Necrosis

## Interventions

- **DRUG:** bevacizumab
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT01621880
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621880, "Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01621880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*